ServiceMaster Global Holdings, Inc. (NYSE: SERV), a leading provider of
essential residential and commercial services, today announced that
Chief Executive Officer Rob Gillette and Chief Financial Officer Alan
Haughie will present at the J.P. Morgan Ultimate Services Investor
Conference 2014 in New York at 2 p.m. Eastern time on Nov.
Merck (NYSE:MRK), known as MSD outside the United States and Canada,
today announced the presentation of results from a multi-arm Phase 2
clinical trial evaluating grazoprevir/elbasvir (MK-5172/MK-8742, the
company’s investigational NS3/4A protease inhibitor and NS5A inhibitor,
respectively) with or without ribavirin (RBV) in treatment-naïve and
previously-treated (with peg-interferon/ribavirin [PR]) patients with
chronic hepatitis C virus (HCV) genotype 1 (GT1) infection --
Sign-up for Merck Announces Results from Phase 2 Study of Investigational Chronic Hepatitis C Treatment Grazoprevir/Elbasvir in Genotype 1 Infected Treatment-Naïve and Difficult-to-Cure Patients investment picks
Cracker Barrel Old Country Store, Inc. (“the “Company”) (Nasdaq:CBRL)
will provide an online, real-time Webcast and rebroadcast of its first
quarter earnings conference call on Tuesday, November 25, beginning at
11:00 a.m. Eastern Time.
(NYSE: CYNI), a leading provider of SDN, NFV, and packet-optical
solutions for network operators, today announced that KVH ,
Asia’s leading information delivery platform headquartered in Tokyo,
Japan, has selected Cyan to upgrade its backhaul network with Cyan’s
ROADM and 100Gbps technology.
Sign-up for Alnylam Expands Hepatic Infectious Disease Pipeline; Adds ALN-HDV for the Treatment of Chronic Hepatitis Delta Virus (HDV) Infection and ALN-PDL for the Treatment of Chronic Liver Infections investment picks
Wesco Aircraft Holdings, Inc. (NYSE: WAIR), a leading provider of
comprehensive supply chain management services to the global aerospace
industry, today announced plans to release its fiscal 2014 fourth
quarter and full-year results after the close of market on Thursday,
November 20, 2014.
Company Completes Acquisition and Integration of EGEN, Inc.; Enrollment Underway in Phase III OPTIMA Study; Initiates Phase II Euro-DIGINTY Study for RCW Breast Cancer; Establishes Clinical Study Plans for EGEN-001
Company to Hold Conference Call on Tuesday, November 11, 2014 at 4:30 p.m. ET LAWRENCEVILLE, N.J. , Nov.
- Strong Revenue and Adjusted EBITDA Growth Across Core Businesses - Airline and Hospitality Solutions Revenue Increased 14.3% Year over Year
- Travel Network Revenue Increased 3.7% Year over Year - Sabre Hospitality Solutions launches SynXis Enterprise Platform - Full Year Adjusted EBITDA and EPS Guidance Reiterated SOUTHLAKE, Texas , Nov.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.